Clinical trial
Long Term Study With B2036-PEG
NCT00143416 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00143416 |
|---|---|
| Title | Long Term Study With B2036-PEG |
| Official title | Long-Term Study of B2036-PEG in Acromegaly - Long Term Study With B2036-PEG - |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acromegaly |
| Intervention type | Drug |
| Interventions | Pegvisomant |
| Enrollment | 16 |
| Start date | Apr 1, 2004 |
| Completion | Jul 1, 2007 |
| First posted | Sep 2, 2005 |
| Last update posted | Jul 29, 2008 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: